The Clinical Utility of 1,25 Dihydroxyvitamin D

Sponsored by: DiaSorin
  • Senior Consultant, Minnesota Personalized Medicine
      Gregory A. Plotnikoff, MD, MTS, FACP, is a board-certified internist and pediatrician in active clinical practice who has received numerous national and international awards for research and education. He is the lead author of one book, 25 textbook chapters and more than 60 articles in the peer-reviewed medical literature. His 2003 article on vitamin D deficiency and chronic, non-specific musculoskeletal pain is one of the most highly-cited articles in the history of the Mayo Clinic Proceedings. He is a graduate of Carleton College, Harvard University Divinity School and the University of Minnesota Medical School.


    Practicing Internist and vitamin D researcher Gregory A. Plotnikoff, MD, MTS, FACP, will review how new testing for 1,25-Dihydroxyvitamin D can enhance your clinical practice. Issues to be addressed include identification of patients most likely to benefit, when to test and how to interpret values. Dr. Plotnikoff will also address the latest data on vitamin D production, utilization and breakdown pathways. The program includes opportunities for questions. This presentation will begin on May 17, 2017, 12pm Eastern Time. Please register now.

    Learning Objectives:

    • Recognize the physiological differences between 25-OH-vitamin D and 1,25 dihydroxyvitamin D including the medical indications for ordering each.
    • Identify the clinical scenarios where precise 1,25-dihydroxyvitamin D measurement supports both diagnosis and treatment.
    • Understand the value in serial measurement of 1,25-dihydroxyvitamin D status in sarcoidosis.
    • Participants will also recognize the emerging literature  which supports the use of 1,25-dihydroxyvitamin D analogues and thus the value in precise measurements to guide therapy.

    Show Resources
    Show Resources
    • See more